Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00347373 · ClinicalTrials.gov registry record · NA

Effect of Conjugated Linoleic Acid Supplement on Body Composition

A NA study of Obesity, sponsored by University of North Carolina.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT00347373: Completed NA study of Obesity, sponsored by University of North Carolina.

NCT00347373 is a NA study of Obesity that has completed, run by University of North Carolina. The registered enrollment target is 60 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00347373, a NA study of Obesity, has completed, sponsored by University of North Carolina.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to examine the effects of a low and high dose of conjugated linoleic acid supplement on body composition in obese humans. Individuals with a body mass index between 30 and 35kg/m2 are randomized to receive either placebo, 3.2gCLA, or 6.4g CLA daily for twelve weeks. Changes in body composition, weight, and clinical laboratory values are compared between the three groups.

Conditions Studied

Interventions

  • DRUG Tonalin Conjugated linoleic acid (dietary supplement)

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2004-08
Est. Completion 2005-09
Phase NA
University of North Carolina

14 total trials

What the finished NCT00347373 record still lists

NCT00347373 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Tonalin Conjugated linoleic acid (dietary supplement) is the first listed.

NCT00347373 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT00347373 about?

NCT00347373 is a clinical study titled "Effect of Conjugated Linoleic Acid Supplement on Body Composition". The purpose of this clinical trial is to examine the effects of a low and high dose of conjugated linoleic acid supplement on body composition in obese humans. Individuals with a body mass index between 30 and 35kg/m2 are randomized to receive either placebo, 3.2gCLA, or 6.4g CLA daily for twelve we...

What is the current status of trial NCT00347373?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2004-08. Estimated completion is 2005-09.

What conditions does trial NCT00347373 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT00347373?

The interventions under investigation include: Tonalin Conjugated linoleic acid (dietary supplement) (DRUG).

Who is sponsoring clinical trial NCT00347373?

This trial is sponsored by University of North Carolina, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00347373 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00347373's enrollment target sits among peer trials

60 642nd of 1053 higher than 374 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00347373, the US trial registry maintained by the National Library of Medicine. NCT00347373 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.